A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Lonza

Company-logo  COMPANY DETAILS
Lonza
Muenchensteinerstrasse 38
Basel
4002
Switzerland


Website
Mail
Call
  +41 61 316 8111


Printer
  +41 61 316 9111

HEALTH CATEGORIES

mobility; sports nutrition


Facebook   
Linkedin   
Twitter   
Youtube   

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment. 

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. 

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources. 

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.

Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.



Articles On Nutrition Insight
FormattedPicture

NUTRITION & HEALTH NEWS

“Reawakening” in joint health: Industry spotlights advancing trends and ingredients

30 Jun 2022 --- Concerns and attention toward joint health are becoming more prominent as consumer lifestyles changed during the COVID-19 pandemic and interest in fitness and health increased.... Read More

FormattedPicture

BUSINESS NEWS

Weekly Roundup: Lonza and IBF create framework agreement, Kemin expands operations to Mexico

27 May 2022 --- This week in nutrition news, Lonza and Israel Biotech Fund (IBF) have partnered for a two-year agreement to support Israeli-based companies with biologics and small molecule... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Gelpell showcases titanium dioxide-free soft and vegan capsules at Vitafoods Europe

11 May 2022 --- Food supplement producer Gelpell is exhibiting its titanium dioxide-free soft capsules as well as vegan soft capsules. NutritionInsight speaks with Kristina Edvinsson, owner of... Read More

FormattedPicture

BUSINESS NEWS

Weekly Roundup: Lonza sells Quakertown site, GOED appoints new exec

06 May 2022 --- This week in nutrition news, Lonza has agreed to sell its US-based Quakertown site to industry investors for an undisclosed amount. The Global Organization for eicosapentaenoic acid... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Lonza’s collagen improves joint flexibility by ten years, study finds

04 May 2022 --- A randomized, double-blind clinical study has shown that a 40 mg daily dose of Lonza Capsules & Health Ingredients UC-II undenatured type II collagen can significantly reverse... Read More




Videos
FormattedPicture

TWK10® sports probiotic for performance nutrition

20 Jun 2022 --- TWK10® sports probiotic is an innovative strain L. plantarum and is the first probiotic clinically proven to increase exercise endurance by up to 75% in athletes of all levels. Learn how TWK10® sports probiotic can help you break through in the competitive global sports and active nutrition categories.

FormattedPicture

Lonza launches white titanium dioxide-free hard gelatin capsules

16 May 2022 --- Amid toughening regulations surrounding titanium dioxide (TiO2) as a whitening ingredient, Lonza is expanding its Capsugel offering to meet TiO2-free requirements for food supplements in the EU. The company’s global product manager Julien Lamps details the opportunities and challenges surrounding the opacifying technology.

FormattedPicture

Navigating TiO2-free capsules

15 Mar 2022 --- In light of the EU’s ban on titanium dioxide, Anne Holderbach explores Lonza’s alternatives for capsules, which use iron oxide for an opaque effect and moderate UV protection. In terms of more vivid semi-opaque options, the company has also developed food-colored capsules.

FormattedPicture

Chr. Hansen demystifies “probiotics jungle” with global online education platform

31 May 2021 --- The “unharmonized” probiotics scene contributes to consumer confusion, which has motivated Chr. Hansen to launch a global online version of The Probiotics Institute. The one-stop-shop educational platform helps consumers navigate the “probiotics jungle” and demystify the human microbiome. Linda Neckmar, VP of commercial development, details why the company has developed a separate version for the Chinese market and how the move coincides with wider company strategies.

FormattedPicture

Forecasting the future of nutrition

22 Dec 2020 --- General health with an emphasis on digestion is set to reach new heights over the coming years as new research emerges, according to Roel van de Put, Lonza Capsules and Health Ingredients’ business development manager. Beauty-from-within, mobility, mood health and immunity will also be major forces shaping the nutritional realm, he predicts. 




Technical Papers
FormattedPicture

TWK10® sports probiotic for performance nutrition

19 Apr 2022 --- TWK10® sports probiotic is an innovative strain L. plantarum and is the first probiotic clinically proven to increase exercise endurance by up to 75% in athletes of all levels.Learn how TWK10® sports probiotic can help you break through in the competitive global sports and active nutrition categories.




Articles On The World of Food Ingredients
FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Opinion Edge: Trends in Supplements and Nutritionals

18 Aug 2020 --- Key suppliers offer their thoughts on the nutritionals industry. Which formats, flavors, and active ingredients are consumers seeking in “the new normal”?




Nutrition Focus
FormattedPicture
12 Oct 2020 | Lonza

Plant-based revolution makes waves in supplements

Consumers are increasingly looking for plant-based offerings and supplements are no exception. Plant-based or vegan claims on supplements grew by 34 percent between 2015 and 2019 and show no... Read More

FormattedPicture
08 Jun 2020 | Lonza

Busy consumers embrace supplements

While differing generations have unique nutritional priorities, they share a desire to live healthy and less stressed lives. This has led many to turn to supplements as an easy way to... Read More

FormattedPicture
24 Oct 2019 | Lonza

Clean label remains king for supplements amid consumer safety concern

Clean label remains king in the supplement space, as consumers who are wary of ingredient traceability and safety are drawn to shorter label lists. Concerns from consumers and lobby groups... Read More

FormattedPicture
18 Mar 2019 | Lonza

Moving with the times: A new generation joint health solution for today’s consumer

The aging consumer has growing expectations of bone and joint health solutions, thanks to the mainstreaming of sports nutrition and a growing focus on active aging. According to Innova... Read More

FormattedPicture
02 Oct 2018 | Lonza

Bone and joint health: Increased focus on mobility and healthy aging

Products featuring bone & joint health claims are on the rise, with Innova Market Insights data showing a compound annual growth rate of 13 percent between 2013 and... Read More




Podcasts
FormattedPicture

NewsBite Podcast (Feb 14 - 18): “Lonza rolls out ‘clock stopping’ sports probiotic to EU market”

21 Feb 2022 --- Today’s NewsBite Podcast details Lonza’s sports probiotic launching in the EU. DSM announced two of its probiotic strains received New Dietary Ingredient status from the FDA, while Calocurb is developing its hop extract Amarasate into a functional food additive that can help suppress appetite.

FormattedPicture

NewsBite Podcast (May 31-Jun 4): “Chr. Hansen and Lonza JV lands manufacturing licenses”

07 Jun 2021 --- This NewsBite podcast delves into Chr. Hansen and Lonza’s joint venture, Bacthera, receiving manufacturing licenses to start supplying live biotherapeutic products. Meanwhile, Probi partnered on probiotic research for vaginal health NPD targeting the “underserved” market. Also, a Safefood report revealed that online conversations about healthy diets are missing input from health experts.

FormattedPicture

NewsBite Podcast (Feb 8-12): “Cargill leads US$55M funding round for Evolve BioSystems’ infant nutrition probiotic”

15 Feb 2021 --- During the last week, Evolve BioSystems landed US$55 million for the commercialization of its “next generation of probiotic.” Other top stories include Lonza’s US$4.7 billion sale of its Speciality Ingredients business and Kappa Bioscience’s US expansion of its vitamin K2 production.

FormattedPicture

NewsBite Podcast (Jan 18-22): Beneo, Gelita and AstaReal spotlight rising e-sports NPD market

25 Jan 2021 --- This week’s NutritionInsight NewsBite podcast looks into e-gaming’s emerging market potential. Recent business news highlights include Lonza’s exit from the softgel arena in the pharma market and other moves in the infant formula sector.




Webinars
FormattedPicture

Plantcaps® capsule essentials

05 Nov 2020 --- For today’s health-conscious and responsible consumers, Lonza’s Capsugel Plantcaps capsules provide the premier balance of product performance and convenience. This webinar dives into the latest market trends, as well as the science and regulatory landscape surrounding Plantcaps.

FormattedPicture

Live Better: Feel good, Stay mobile. Formulation strategies for today’s consumer

24 Jun 2020 --- Supplement users increasingly aspire to more sustainable, health-focused ideals and are on the hunt for high-quality, responsibly sourced products that help them to stay mobile and live better. In this webinar, Lonza experts delve into how these preferences extend across a range of emerging, on-demand consumer trends, from joint and cognitive health to probiotics and beauty-from-within.

FormattedPicture

Tio2 free: Clear path to compliance

08 Nov 2019 --- This webinar will discuss how food supplement makers can address the rising consumer demand for clean and clear label solutions in light of the changing regulatory environment regarding the use of titanium dioxide as an opacifier. It will also explore how Lonza’s new Vcaps® Plus WHITE OPAL® capsule is designed to perform and can support producers to meet this growing need in today’s market.

FormattedPicture

Moving with the times: a new generation joint health solution for today’s consumer

28 Mar 2019 --- The NutritionInsight webinar “Moving with the times: a new generation joint health solution for today’s consumer” offers insights into the changing consumer landscape, including the expectations of both aging and active consumers and rising demand for joint health solutions. Dominik Mattern of Lonza Capsugel discusses the science behind Lonza’s UC-II undenatured type II collagen ingredient, including its unique mode of action and how it can meet the needs of a new and growing consumer base. He presents a first look at Lonza’s new generation of ready-to-market innovative dosage forms and formulations that address mobility concerns related to healthy aging.

FormattedPicture

Driving growth in the joint health category: UC-II® undenatured type II collagen

19 Oct 2018 --- UC-II® undenatured type II collagen is a once-a-day joint health solution for the joint health market. Its small dose size and mode of action help make it the preferred choice among top food supplement manufacturers and retailers. Learn why UC-II® undenatured type II collagen is a success story and discover new ready-to-market solutions.




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W